- Report
- May 2024
- 200 Pages
Global
From €3746EUR$4,150USD£3,247GBP
- Report
- March 2024
- 200 Pages
Global
From €3746EUR$4,150USD£3,247GBP
- Report
- August 2023
- 145 Pages
Global
From €2843EUR$3,150USD£2,465GBP
- Report
- April 2026
- 113 Pages
Global
From €4287EUR$4,750USD£3,717GBP
- Report
- May 2025
- 114 Pages
Global
From €4287EUR$4,750USD£3,717GBP
- Report
- July 2024
- 120 Pages
Global
From €4287EUR$4,750USD£3,717GBP
- Report
- February 2024
- 115 Pages
Global
From €4287EUR$4,750USD£3,717GBP
- Report
- February 2024
- 131 Pages
Global
From €4287EUR$4,750USD£3,717GBP
- Report
- April 2023
- 115 Pages
Global
From €4287EUR$4,750USD£3,717GBP
- Report
- June 2025
- 400 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- June 2025
- 400 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- June 2025
- 400 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- August 2024
- 150 Pages
Global
From €2517EUR$2,789USD£2,182GBP
- Report
- August 2024
- 200 Pages
Global
From €3492EUR$3,869USD£3,027GBP
- Report
- August 2024
- 200 Pages
Global
From €3492EUR$3,869USD£3,027GBP
- Report
- August 2024
- 150 Pages
Global
From €2517EUR$2,789USD£2,182GBP
- Report
- August 2024
- 150 Pages
Global
From €2517EUR$2,789USD£2,182GBP
- Report
- May 2024
- 140 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- September 2023
- 160 Pages
Global
From €3248EUR$3,599USD£2,816GBP
- Report
- April 2023
- 147 Pages
Global
From €4467EUR$4,949USD£3,872GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more